Clinical trial Recruiting at 1 site Observational Ages 18 and up

Measuring Atrial Pressure Changes During a Combined Heart Procedure

Official title: The Impact of Atrial Pressure Change Before and After One-stop Procedure Combining Catheter Ablation and Left Atrial Appendage Closure on the Prognosis of Patients With Atrial Fibrillation

Run by Shanghai 10th People's Hospital · NCT05106270 · Data updated 2026-11-12

This study is testing how changes in heart pressure during a combined procedure can affect the health of patients with atrial fibrillation who are at high risk for stroke or bleeding.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorShanghai 10th People's Hospital
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedNovember 10, 2021
Main results expectedNovember 10, 2023
Study endsNovember 10, 2027
Registry record updatedSeptember 2, 2022
Trial IDNCT05106270 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 with atrial fibrillation who are at high risk of stroke or bleeding and are eligible for left atrial appendage closure.

Probably not a fit

Patients with reversible causes of atrial fibrillation or those who have had previous cardiac surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to measure the changes in left and right atrial pressure before and after a combined procedure involving catheter ablation and left atrial appendage closure in patients with atrial fibrillation. The study will recruit patients who are at high risk of stroke or bleeding and are eligible for the procedure. The researchers will investigate how these pressure changes affect clinical outcomes, particularly in relation to heart failure progression. The methodology includes using transseptal puncture to measure atrial pressures during the procedure.

Why it matters

Potential benefit: If successful, this study could provide insights into managing atrial pressure changes, potentially improving outcomes for patients undergoing combined procedures for atrial fibrillation.

How similar studies have gone: While there have been studies on catheter ablation and left atrial appendage closure separately, this specific investigation into atrial pressure changes during a combined procedure is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Atrial fibrillation recorded by 12-lead ECG or Holter that last for longer than 30 seconds within the preceding 6 months;
* Eligible for left atrial appendage closure, that meet at least one of the followings:

  1. At high risk of stroke (CHA2DS2-VASc score≥3 in female, ≥2 in male) and/or bleeding (HAS-BLED score≥3);
  2. Contraindicated to oral anticoagulation (OAC);
  3. Refused OAC treatment albeit comprehensively informed of the necessity and benefits of OAC treatment.
* Capable of understanding and signing the informed consent form.
* Aged over 18 years.

Exclusion Criteria:

* Reversible causes of atrial fibrillation, including thyroid disorders, recent major surgery, trauma, acute alcoholic intoxication;
* Concomitant arrhythmia including atrial flutter, ventricular tachycardia;
* A previous history of atrial fibrillation surgery (MAZE surgery) or catheter ablation;
* A previous history of cardiac surgery including any valvular replacement, septal repair;
* A recent history of major cardiovascular disease within 3 months, including acute myocardial infarction, ventricular fibrillation;
* A history of congenital heart disease;
* A previous history of atrioventricular node ablation;
* A history of lobectomy due to any medical condition;
* Complicated by other diseases with life expectation \<1 year;
* Women with childbearing potential;
* Participated in other interventional clinical trials that might affect prognosis;
* Unable to understand or give informed consent form.

Where it's running

  • Department of Cardiology, Shanghai Tenth People's Hospital
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.